BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27001088)

  • 1. Exonic rearrangements in the known Parkinson's disease-causing genes are a rare cause of the disease in South African patients.
    van der Merwe C; Carr J; Glanzmann B; Bardien S
    Neurosci Lett; 2016 Apr; 619():168-71. PubMed ID: 27001088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of exon dosage using MLPA in South African Parkinson's disease patients.
    Keyser RJ; Lombard D; Veikondis R; Carr J; Bardien S
    Neurogenetics; 2010 Jul; 11(3):305-12. PubMed ID: 20013014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Exon Dosage Using Multiplex Ligation-Dependent Probe Amplification in Chinese Patients with Early-Onset Parkinson's Disease.
    Lin Y; Zeng YF; Cai NQ; Lin XZ; Wang N; He J
    Eur Neurol; 2019; 81(5-6):246-253. PubMed ID: 31618739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the parkin gene are a minor cause of Parkinson's disease in the South African population.
    Haylett WL; Keyser RJ; du Plessis MC; van der Merwe C; Blanckenberg J; Lombard D; Carr J; Bardien S
    Parkinsonism Relat Disord; 2012 Jan; 18(1):89-92. PubMed ID: 21996382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.
    Scarciolla O; Brancati F; Valente EM; Ferraris A; De Angelis MV; Valbonesi S; Garavaglia B; Uncini A; Palka G; Stuppia L; Dallapiccola B
    Mov Disord; 2007 Nov; 22(15):2274-8. PubMed ID: 17914726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
    Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
    Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of PARK2 gene exon rearrangements in Russian patients with sporadic Parkinson's disease.
    Semenova EV; Shadrina MI; Slominsky PA; Ivanova-Smolenskaya IA; Bagyeva G; Illarioshkin SN; Limborska SA
    Mov Disord; 2012 Jan; 27(1):139-42. PubMed ID: 21915905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients.
    Darvish H; Movafagh A; Omrani MD; Firouzabadi SG; Azargashb E; Jamshidi J; Khaligh A; Haghnejad L; Naeini NS; Talebi A; Heidari-Rostami HR; Noorollahi-Moghaddam H; Karkheiran S; Shahidi GA; Paknejad SM; Ashrafian H; Abdi S; Kayyal M; Akbari M; Pedram N; Emamalizadeh B
    Neurosci Lett; 2013 Sep; 551():75-8. PubMed ID: 23880019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
    Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Han Chinese family with early-onset Parkinson's disease carries novel compound heterozygous mutations in the PARK2 gene.
    Huang T; Gao CY; Wu L; Gong PY; Wang JZ; Tian YY; Zhang YD
    Brain Behav; 2019 Sep; 9(9):e01372. PubMed ID: 31386307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease.
    Bardien S; Keyser R; Yako Y; Lombard D; Carr J
    Parkinsonism Relat Disord; 2009 Feb; 15(2):116-21. PubMed ID: 18514563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic instability in the PARK2 locus is associated with Parkinson's disease.
    Ambroziak W; Koziorowski D; Duszyc K; Górka-Skoczylas P; Potulska-Chromik A; Sławek J; Hoffman-Zacharska D
    J Appl Genet; 2015 Nov; 56(4):451-461. PubMed ID: 25833766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon dosage variations in Brazilian patients with Parkinson's disease: analysis of SNCA, PARKIN, PINK1 and DJ-1 genes.
    Moura KC; Junior MC; de Rosso AL; Nicaretta DH; Pereira JS; José Silva D; Santos-Rebouças CB; Pimentel MM
    Dis Markers; 2012; 32(3):173-8. PubMed ID: 22377733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients.
    Koziorowski D; Hoffman-Zacharska D; Sławek J; Jamrozik Z; Janik P; Potulska-Chromik A; Roszmann A; Tataj R; Bal J; Friedman A
    Neurol Neurochir Pol; 2013; 47(4):319-24. PubMed ID: 23986421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective quantitative real-time polymerase chain reaction analysis of the parkin gene (PARK2) exon 1-12 dosage.
    Shadrina MI; Semenova EV; Slominsky PA; Bagyeva GH; Illarioshkin SN; Ivanova-Smolenskaia II; Limborska SA
    BMC Med Genet; 2007 Feb; 8():6. PubMed ID: 17324265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2.
    Kay DM; Stevens CF; Hamza TH; Montimurro JS; Zabetian CP; Factor SA; Samii A; Griffith A; Roberts JW; Molho ES; Higgins DS; Gancher S; Moses L; Zareparsi S; Poorkaj P; Bird T; Nutt J; Schellenberg GD; Payami H
    Neurology; 2010 Sep; 75(13):1189-94. PubMed ID: 20876472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkin mutations in familial and sporadic Parkinson's disease among Indians.
    Chaudhary S; Behari M; Dihana M; Swaminath PV; Govindappa ST; Jayaram S; Goyal V; Maitra A; Muthane UB; Juyal RC; Thelma BK
    Parkinsonism Relat Disord; 2006 May; 12(4):239-45. PubMed ID: 16500134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.
    Ben-Shachar S; Afawi Z; Masalha R; Badarny S; Neiman T; Pavzner D; Bar-Shira A; Orr-Urtreger A
    J Mol Neurosci; 2017 Oct; 63(2):216-222. PubMed ID: 28913705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution survey in familial Parkinson disease genes reveals multiple independent copy number variation events in PARK2.
    Wang L; Nuytemans K; Bademci G; Jauregui C; Martin ER; Scott WK; Vance JM; Zuchner S
    Hum Mutat; 2013 Aug; 34(8):1071-4. PubMed ID: 23616242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.